Evidence map›Paper›PMID 34183310›Full record

ArticleBMJ case reports2021

Pneumocystis in metastatic lung cancer, a pragmatic approach in support of prophylaxis.

David Luque Paz, Stephane Jouneau, Pierre Tattevin, Charles Ricordel

Open access · hybridAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in BMJ case reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Global trends, risk factors, and therapeutic associations of fungal pulmonary infections in lung cancer: A systematic review and meta-analysis.Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia · 2025
    Pooled it
  2. Article
  3. [Pneumocystis jirovecii Pneumonia in Patients with Lung Cancer: A Review].Zhongguo fei ai za zhi = Chinese journal of lung cancer · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

David Luque PazInfectious Diseases and Intensive Care Unit, CHU Rennes, Rennes, France.
Stephane JouneauDepartment of Respiratory Medicine, Centre Hospitalier Universitaire de Rennes, Rennes, France.
Pierre TattevinInfectious Diseases and Intensive Care Unit, CHU Rennes, Rennes, France.
Charles RicordelDepartment of Respiratory Medicine, Centre Hospitalier Universitaire de Rennes, Rennes, France charles.ricordel@chu-rennes.fr.ORCID http://orcid.org/0000-0001-6160-2732
Centre Hospitalier Universitaire de Rennes · FROncogenesis Stress Signaling · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lung cancer prognosis has improved in the last decade, including in patients with brain metastasis. However, few of these patients who receive corticosteroids have a primary prophylaxis for

Indexed as

Carcinoma, Non-Small-Cell LungLung NeoplasmsPneumocystisPneumocystis cariniiPneumonia, PneumocystisAged, 80 and overHumansImmunocompromised HostMalelung cancer (oncology)pneumonia (respiratory medicine)

Identifiers

PMID34183310
PMCPMC8240585
OpenAlexW3173999488

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.